Cited by 103HIV Research and TreatmentHIV/AIDS drug development and treatmentInfectious Diseases and Tuberculosis

HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches

Open access
Kaul, Marcus·2009·Current Opinion in Neurology

Abstract

PURPOSE OF REVIEW: Infection with HIV-1 can induce dementia despite successful administration of life-prolonging highly active antiretroviral therapy. This review will discuss recent progress toward a better understanding of the pathogenesis and an improved design of therapies for HIV-associated neurocognitive disorders. RECENT FINDINGS: Highly active antiretroviral therapy prolongs the lives of HIV patients, but the incidence of HIV-associated dementia as an AIDS-defining illness has increased and the brain is now recognized as a viral sanctuary that requires additional therapeutic effort. The neuropathology of HIV infection also has changed due to improved therapy, and while more similarities with other neurodegenerative diseases are being reported, predictive biomarkers remain elusive. However, improvements of in-vivo imaging technology and progress in uncovering the molecular mechanisms of HIV disease keep providing new insights. As such it appears that a prolonged activation of the immune system by HIV eventually leads to AIDS, and several lines of evidence indicate that simultaneously neurotoxic processes and impairment of neurogenesis both contribute to the development of HIV-associated neurocognitive disorders. SUMMARY: The improved understanding of the interaction between HIV and its human host provides hope that adjunctive therapies to antiretroviral treatment can be developed for HIV-associated neurocognitive disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/wco.0b013e328329cf3c

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some HIV patients develop severe HAND (HAD) with motor and cognitive symptoms typical of Alzheimer patients.

    “Although this condition is normally mild, some patients can develop a highly severe form of HAND known as HIV‐associated dementia (HAD), associated with extreme motor and cognitive symptoms typical of Alzheimer patients (Kaul, 2009).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kaul, M.
Affiliations
Sanford Burnham Prebys Medical Discovery Institute (US)
Corresponding author
Kaul, Marcus
Venue
Current Opinion in Neurology
Published
2009-06
Volume
22
Issue
3
Pages
315-320
ISSN
1350-7540 (ISSN-L)
OpenAlex
W2039285894
Cited by
103
References
51
Citations by year
2025: 5 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 9 · 2014: 17 · 2013: 9 · 2012: 9
FWCI
1.01
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS050621)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
Keywords
HIV-associated dementia, HIV-associated neurocognitive disorders, HIV neuropathology, highly active antiretroviral therapy, neuroinflammation, neurotoxicity, predictive biomarkers, adjunctive therapy, in vivo brain imaging, neurodegenerative diseases
MeSH terms
Humans, Biomarkers, HIV-1, AIDS Dementia Complex, Anti-HIV Agents, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review